For topical skin protocols, GHK-Cu is commonly applied to areas such as the face, neck, chest, or other areas your provider recommends
Eli Lilly positions Mounjaro and Zepbound in the same category as Ozempic and Wegovy because they treat the same conditions and use similar injection devices
Despite decades of research and medical advancements, significant challenges remain
This kind of trial is expensive typically several million dollars and to date has been more difficult to justify economically because GHK-Cu cannot be patented as a novel drug (the molecule is endogenous and the relevant patents have expired)
The Precision Peptide Genetic Test is a one-time analysis of pathway-level variants such as FTO, GLP1R, MC4R, and TCF7L2, independent of any subscription